Zhejiang Hisoar Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.20%

Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has an Asset Resilience Ratio of 0.20% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Zhejiang Hisoar Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥14.71 Million

≈ $2.15 Million USD Cash + Short-term Investments

Total Assets

CN¥7.28 Billion

≈ $1.06 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2003–2024)

This chart shows how Zhejiang Hisoar Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Zhejiang Hisoar Pharmaceutical Co Ltd net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Hisoar Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002099 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥14.71 Million	0.2%
Total Liquid Assets	CN¥14.71 Million	0.20%

Asset Resilience Insights

Limited Liquidity: Zhejiang Hisoar Pharmaceutical Co Ltd maintains only 0.20% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Hisoar Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Hisoar Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	3.73%
Yuhan Corp. KO:000100	Drug Manufacturers - Specialty & Generic	0.99%
Tasly Pharmaceutical Group Co Ltd SHG:600535	Drug Manufacturers - Specialty & Generic	9.09%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.02%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%

Annual Asset Resilience Ratio for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2024)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Hisoar Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.60%	CN¥45.03 Million ≈ $6.59 Million	CN¥7.46 Billion ≈ $1.09 Billion	+0.49pp
2021-12-31	0.12%	CN¥9.48 Million ≈ $1.39 Million	CN¥8.02 Billion ≈ $1.17 Billion	-2.01pp
2018-12-31	2.13%	CN¥150.00 Million ≈ $21.95 Million	CN¥7.04 Billion ≈ $1.03 Billion	+1.46pp
2017-12-31	0.67%	CN¥50.00 Million ≈ $7.32 Million	CN¥7.47 Billion ≈ $1.09 Billion	+0.67pp
2014-12-31	0.00%	CN¥119.75K ≈ $17.52K	CN¥4.17 Billion ≈ $609.83 Million	-0.04pp
2011-12-31	0.04%	CN¥561.04K ≈ $82.10K	CN¥1.44 Billion ≈ $210.01 Million	-0.02pp
2006-12-31	0.05%	CN¥500.00K ≈ $73.17K	CN¥921.93 Million ≈ $134.91 Million	-0.08pp
2005-12-31	0.14%	CN¥800.00K ≈ $117.07K	CN¥576.72 Million ≈ $84.39 Million	-0.01pp
2004-12-31	0.15%	CN¥576.32K ≈ $84.33K	CN¥387.38 Million ≈ $56.69 Million	-1.14pp
2003-12-31	1.29%	CN¥4.67 Million ≈ $683.58K	CN¥362.38 Million ≈ $53.03 Million	--

pp = percentage points

About Zhejiang Hisoar Pharmaceutical Co Ltd

SHE:002099 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.50 Billion

CN¥10.26 Billion CNY

Market Cap Rank

#7380 Global

#1762 in China

Share Price

CN¥6.34

Change (1 day)

-3.65%

52-Week Range

CN¥5.05 - CN¥8.83

All Time High

CN¥11.31